Inhibition of 14-3-3/Tau by Hybrid Small-Molecule Peptides Operating via Two Different Binding Modes

[Image: see text] Current molecular hypotheses have not yet delivered marketable treatments for Alzheimer’s disease (AD), arguably due to a lack of understanding of AD biology and an overreliance on conventional drug modalities. Protein–protein interactions (PPIs) are emerging drug targets, which sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Andrei, Sebastian A., Meijer, Femke A., Neves, João Filipe, Brunsveld, Luc, Landrieu, Isabelle, Ottmann, Christian, Milroy, Lech-Gustav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256345/
https://www.ncbi.nlm.nih.gov/pubmed/29722962
http://dx.doi.org/10.1021/acschemneuro.8b00118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256345/
https://www.ncbi.nlm.nih.gov/pubmed/29722962
http://dx.doi.org/10.1021/acschemneuro.8b00118

Ejemplares similares